Regeneron Pharmaceuticals Analysts Recommendations and Consensus

Regeneron Pharmaceuticals Inc -- USA Stock  

USD 374.07  2.54  0.68%

The current analyst and expert consensus on Regeneron Pharmaceuticals is Hold with 10 hold recommendations. The current projected target price consensus is 428.29 with 14 analysts opinions. One of the most common ways Regeneron Pharmaceuticals analysists use to provide buy or sell recommendation to public are conference calls analysis and financial statements evaluations. Some experts can also talk to Regeneron Pharmaceuticals vendors, executives, and/or customers. Regeneron Pharmaceuticals recommendation module provides expert sentiment on the projected Regeneron Pharmaceuticals target price to derive its highest and lowest estimates based on target price standard deviation of 65.584. Additionally take a look at Macroaxis Advice on Regeneron Pharmaceuticals to cross-verify analyst projections. Unlike analyst recommendations, Macroaxis provides advice only from the prospective of investor risk tolerance and investment horizon.

Regeneron Pharmaceuticals Target Price Consensus

Number of Opinions18
Lowered Outlook0
Raized Outlook0
Macroaxis Recommendation   Exposure   Valuation

Current Price

Regeneron Pharmaceuticals Market Quote
Low Price370.28Odds
High Price378.7Odds


Target Price

Analyst Consensus On Target Price
Low Estimate345.0Odds
High Estimate598.0Odds
Number of Analysts14
Standard Deviation65.584


Regeneron Pharmaceuticals Analysit Ratings

Average Consensus